START Clinic for Mood and Anxiety Disorders
Toronto, Ontario, Canada
Wellness center in Toronto, Ontario
32 Park Rd, Toronto, ON M4W 2N4
About START Clinic for Mood and Anxiety Disorders
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
START Clinic for Mood and Anxiety Disorders
4
Biohaven Pharmaceuticals, Inc.
2
Shire
2
Dr. Martin A. Katzman
1
Clinical Trials at START Clinic for Mood and Anxiety Disorders
During the past decade, START Clinic for Mood and Anxiety Disorders conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
2011-10-27
2013-12-23
Completed
1,262
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
2012-02-27
2014-03-27
Terminated
1,570
Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities
2013-01-01
2020-05-01
Completed
29
Adjunctive Vitamin D in the Treatment of Non-remitted Depression
2013-12-01
2017-05-01
Terminated
9
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
2021-01-29
2023-12-15
Recruiting
700
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
2021-03-30
2025-06-01
Enrolling by invitation
1,200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "START Clinic for Mood and Anxiety Disorders"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "The Canadian College of Naturopathic Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at START Clinic for Mood and Anxiety Disorders
According to Clinical.Site data, the most researched conditions in "START Clinic for Mood and Anxiety Disorders" are
"Major Depressive Disorder" (2 trials), "Social Anxiety Disorder" (2 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Depression" (1 trials) and "Generalized Anxiety Disorder" (1 trials). Many other conditions were trialed in "START Clinic for Mood and Anxiety Disorders" in a lesser frequency.
Clinical Trials Intervention Types at START Clinic for Mood and Anxiety Disorders
Most popular intervention types in "START Clinic for Mood and Anxiety Disorders" are "Drug" (8 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Active" (1 trials), "Cariprazine" (1 trials), "Cipralex" (1 trials) and "Desvenlafaxine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at START Clinic for Mood and Anxiety Disorders
The vast majority of trials in "START Clinic for Mood and Anxiety Disorders" are
9 trials for "All" genders.
Clinical Trials Status at START Clinic for Mood and Anxiety Disorders
Currently, there are NaN active trials in "START Clinic for Mood and Anxiety Disorders".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 4 completed trials in START Clinic for Mood and Anxiety Disorders,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in START Clinic for Mood and Anxiety Disorders, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".